{"product_id":"cst-11930t","title":"CST,  11930T, IKK alpha (3G12) Mouse Monoclonal Antibody","description":"Monoclonal Antibody for studying IKK-alpha. Validated for Western Blotting,Immunofluorescence (Immunocytochemistry). Available in 2 sizes. Highly specific and rigorously validated in-house, IKK alpha (3G12) Mouse Monoclonal Antibody (CST #11930) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\nImmunofluorescence (Immunocytochemistry): 1:400 - 1:1600\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at -20°C. Do not aliquot the antibody. For a carrier free (BSA and azide free) version of this product see product # 49706 .\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting, Immunofluorescence (Immunocytochemistry)\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nIKK alpha (3G12) Mouse Monoclonal Antibody recognizes endogenous levels of total IKKÎ± protein.\nSpecies Reactivity: Human, Monkey\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nMonoclonal antibody is produced by immunizing animals with a recombinant protein specific to a carboxy-terminal fragment of human IKKÎ± protein.\n\u003cb\u003eBackground\u003c\/b\u003e\nThe NF-ÎºB\/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IÎºB proteins (1-3). Most agents that activate NF-ÎºB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IÎºB (3-7). The key regulatory step in this pathway involves activation of a high molecular weight IÎºB kinase (IKK) complex whose catalysis is generally carried out by three tightly associated IKK subunits. IKKÎ± and IKKÎ² serve as the catalytic subunits of the kinase and IKKÎ³ serves as the regulatory subunit (8,9). Activation of IKK depends upon phosphorylation at Ser177 and Ser181 in the activation loop of IKKÎ² (Ser176 and Ser180 in IKKÎ±), which causes conformational changes, resulting in kinase activation (10-13).\n\u003cb\u003eAlternate Names\u003c\/b\u003e\nCHUK; component of inhibitor of nuclear factor kappa B kinase complex; conserved helix-loop ubiquitous kinase; Conserved helix-loop-helix ubiquitous kinase; I-kappa-B kinase 1; I-kappa-B kinase alpha; I-kappa-B kinase-alpha; IkappaB kinase; IkB kinase alpha subunit; IkBKA; IKK-A; IKK-a kinase; IKK-alpha; IKK1; IKKA; Inhibitor of nuclear factor kappa-B kinase subunit alpha; NFKBIKA; Nuclear factor NF-kappa-B inhibitor kinase alpha; Nuclear factor NFkappaB inhibitor kinase alpha; TCF-16; TCF16; Transcription factor 16\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H Mk\nSENSITIVITY: Endogenous\nMW (kDa): 85\nSource\/Isotype: Mouse IgG1","brand":"CST","offers":[{"title":"Default Title","offer_id":46797561823401,"sku":"11930T","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-11930t","provider":"Iright","version":"1.0","type":"link"}